Clinical Trial Update: Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

View source ↗

Summary

A completed clinical trial update reports results from a survey of adherence to Arimidex (anastrozole) among women with early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED